Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Probuphine completes pilot study for opiate addiction

June 8, 2004

Progress of dopamine D1-selective antagonist lines up milestones for CeNeS

May 28, 2004

ICS-205930 enhances naltrexone-induced suppression of ethanol consumption

May 24, 2004

European Commission broadens Ferriprox indication

May 17, 2004

Baclofen reported to reduce drug use in cocaine-dependent subjects

May 11, 2004

Additional data requested prior to 510(k) clearance of UPlink(R) system

March 31, 2004

Orphan drug status for sodium thiosulfate

March 26, 2004

Anticalin shows promise in vitro

March 16, 2004

Positive phase I/II results for NicVAX

March 4, 2004

Cytos' Immunodrug for nicotine addiction enters phase II trial in smokers

Jan. 20, 2004

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...